Evidence map›Paper›PMID 33028563›Full record

SynthesisBMJ open2020

Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis.

Biruk Beletew Abate, Ayelign Mengesha Kassie, Mesfin Wudu Kassaw, Teshome Gebremeskel Aragie, Setamlak Adane Masresha

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 160 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
160citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

160 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2022
    Pooled it
  9. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Pooled it
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  20. Article

100 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Biruk Beletew AbateNursing, Woldia University, Woldia, Amhara, Ethiopia birukkelemb@gmail.com.ORCID 0000-0003-0833-2504
Ayelign Mengesha KassieNursing, Woldia University, Woldia, Amhara, Ethiopia.ORCID 0000-0003-1505-9390
Mesfin Wudu KassawNursing, Woldia University, Woldia, Amhara, Ethiopia.ORCID 0000-0002-6327-7723
Teshome Gebremeskel AragieNursing, Woldia University, Woldia, Amhara, Ethiopia.
Setamlak Adane MasreshaCollege of Health Sciences, Department of Public Health, Woldia University, Woldia, Amhara, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the sex difference in the prevalence of COVID-19 confirmed cases.

designSystematic review and meta-analysis.

settingPubMed, Cochrane Library and Google Scholar were searched for related information. The authors developed a data extraction form on an Excel sheet and the following data from eligible studies were extracted: author, country, sample size, number of female patients and number of male patients. Using STATA V.14 for analysis, the authors pooled the overall prevalence of men and/or women using a random-effect meta-analysis model. The authors examined the heterogeneity in effect size using Q statistics and I

participantsStudies on COVID-19 confirmed cases were included.

interventionSex (male/female) of COVID-19 confirmed cases was considered. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was prevalence of COVID-19 among men and women.

resultsA total of 57 studies with 221 195 participants were used in the analysis. The pooled prevalence of COVID-19 among men was found to be 55.00 (51.43-56.58, I

conclusionsThe prevalence of symptomatic COVID-19 was found to be higher in men than in women. The high prevalence of smoking and alcohol consumption contributed to the high prevalence of COVID-19 among men. Additional studies on the discrepancies in severity and mortality rate due to COVID-19 among men and women and the associated factors are recommended.

Indexed as

Gender IdentityPandemicsAlcohol DrinkingBetacoronavirusCoronavirusCoronavirus InfectionsCOVID-19FemaleHumansMalePneumonia, ViralSARS-CoV-2Sex FactorsSmokingepidemiologyimmunologyinfectious diseases

Identifiers

PMID33028563
PMCPMC7539579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.